Endoscopy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

The Global Endoscopy Market was valued at USD 29.5 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 56.9 billion by 2034, driven by increasing demand for minimally invasive procedures, a rising geriatric population, and growing incidences of gastrointestinal, respiratory, and urologic disorders. Endoscopy enables early diagnosis and treatment with reduced patient discomfort and quicker recovery times, making it an essential tool in modern medicine. Certainly! Here's an expanded version of the paragraph with added depth and context:

Technological innovations such as AI-assisted endoscopy, robotic-assisted systems, high-definition (HD) visualization, and capsule endoscopy are revolutionizing diagnostic accuracy and procedural efficiency across clinical specialties. AI algorithms are being integrated into endoscopic platforms to assist in real-time lesion detection, classification, and documentation, particularly in gastrointestinal procedures, enhancing early diagnosis of conditions like colorectal cancer. Robotic-assisted systems enable higher precision in complex procedures by offering maneuverability, reducing operator fatigue, and minimizing patient trauma. Meanwhile, HD and 4K endoscopic imaging systems provide superior visualization of internal structures, allowing for more accurate diagnoses and targeted interventions. Capsule endoscopy, a minimally invasive solution that uses a swallowable camera, is becoming increasingly popular for small intestine imaging and patients who cannot tolerate traditional endoscopy.

Endoscopes remained the dominant product segment in 2024, generating USD 14.5 billion, due to their integral role in diagnostic and therapeutic interventions across gastroenterology, pulmonology, urology, orthopedics, and gynecology. Continued development of single-use and antimicrobial-coated endoscopes is addressing infection control challenges and enhancing safety in outpatient and hospital settings. The demand for flexible endoscopes is also rising due to their ability to access anatomically complex regions with minimal discomfort.

Hospitals represented the largest end-use segment, forecast to reach USD 34.8 billion by 2034, driven by their centralized resources, experienced specialists, and growing patient intake. Hospitals invest in integrated diagnostic suites that combine imaging, navigation, and reporting software, streamlining workflows and boosting procedural throughput. Additionally, hospitals often serve as key hubs for research and clinical trials, accelerating the adoption of next-generation endoscopy technologies.

North America Endoscopy Market held the largest market, generated USD 11.7 billion in 2024, with projections reaching USD 21.4 billion by 2034, owing to its early adoption of cutting-edge technologies, strong presence of global medtech manufacturers, and extensive reimbursement frameworks. The region also benefits from proactive government initiatives promoting preventive care, which has led to a surge in colorectal cancer screenings and upper GI procedures. Moreover, increasing healthcare expenditure, aging demographics, and the rapid rollout of AI-integrated platforms are consolidating North America’s position as a global leader in the endoscopy market.

To solidify their market presence, leading companies in the Global Endoscopy Market, such as Olympus Corporation, Boston Scientific, Stryker, Medtronic, and Karl Storz, are adopting multifaceted strategies. These include expanding product portfolios through innovations like disposable endoscopes, AI-powered imaging, and robotic-assisted systems. Companies invest in regional expansion, especially in Asia-Pacific and Latin America, through partnerships and local manufacturing. Strategic acquisitions and collaborations with digital health startups enable the integration of smart diagnostics and cloud-based platforms. Emphasis on training programs, direct-to-hospital sales models, and improving reprocessing technologies enhances procedural safety and efficiency. Additionally, increased focus on outpatient care and ambulatory surgical centers drives demand for compact, high-performance systems tailored to low-resource or high-throughput settings.


Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Company revenue share analysis
1.4.2 Approach 2: Bottom-up approach
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Application trends
2.1.5 End use trends
Chapter 3 Industry Insights
3.1 Industry ecosystem
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population globally
3.2.1.2 Introduction of technologically advanced endoscopes
3.2.1.3 Rising incidences of gastrointestinal disorders, cancer, and other
chronic conditions
3.2.1.4 Increasing demand for minimally invasive procedures
3.2.2 Industry pitfall
3.2.2.1 Dearth of skilled physicians and endoscopists in developing countries
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter’s analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Future market trends
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Olympus Corporation
4.1.2 Boston Scientific Corporation
4.1.3 Stryker Corporation
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Endoscopy Market, By Product
5.1 Endoscopes
5.1.1 Rigid endoscopes
5.1.2 Flexible endoscopes
5.1.3 Capsule endoscopes
5.2 Visualization systems
5.3 Endoscopic ultrasound
5.4 Insufflator
5.5 Other products
Chapter 6 Endoscopy Market, By Application
6.1 Laparoscopy
6.2 GI endoscopy
6.2.1 Gastroscopy
6.2.2 Colonoscopy
6.2.3 Sigmoidoscopy
6.2.4 Duodenoscopy
6.2.5 Other GI endoscopies
6.3 Arthroscopy
6.4 ENT endoscopy
6.5 Pulmonary endoscopy
6.6 Obstetrics/Gynecology
6.7 Other applications
Chapter 7 Endoscopy Market, By End Use
7.1 Hospitals
7.2 Ambulatory surgical centers
7.3 Other end users
Chapter 8 Endoscopy Market, By Region
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Latin America
8.5 Middle East and Africa
Chapter 9 Company Profiles
9.1 B. Braun
9.1.1 Financial data
9.1.1.1 Sales revenue, 2021-2024 (USD Million)
9.1.2 Product landscape
9.1.3 Strategic outlook
9.1.4 SWOT analysis
9.2 Boston Scientific Corporation
9.2.1 Financial data
9.2.1.1 Sales revenue, 2021-2024 (USD Million)
9.2.2 Product landscape
9.2.3 Strategic outlook
9.2.4 SWOT analysis
9.3 CONMED Corporation
9.3.1 Financial data
9.3.1.1 Sales revenue, 2021-2024 (USD Million)
9.3.2 Product landscape
9.3.3 SWOT analysis
9.4 Cook Medical
9.4.1 Financial data
9.4.2 Product landscape
9.4.3 Strategic outlook
9.4.4 SWOT analysis
9.5 Ethicon US, LLC (Johnson & Johnson)
9.5.1 Financial data
9.5.1.1 Sales revenue, 2021-2024 (USD Million)
9.5.2 Product landscape
9.5.3 Strategic outlook
9.5.4 SWOT analysis
9.6 Fujifilm Holdings Corporation
9.6.1 Financial data
9.6.1.1 Sales revenue, 2020-2023 (USD Million)
9.6.2 Product landscape
9.6.3 Strategic outlook
9.6.4 SWOT analysis
9.7 Hoya Corporation
9.7.1 Financial data
9.7.1.1 Sales revenue, 2020-2023 (USD Million)
9.7.2 Product landscape
9.7.3 Strategic outlook
9.7.4 SWOT analysis
9.8 Intuitive Surgical, Inc.
9.8.1 Financial data
9.8.1.1 Sales revenue, 2021-2024 (USD Million)
9.8.2 Product landscape
9.8.3 SWOT analysis
9.9 Karl Storz
9.9.1 Financial data
9.9.2 Product landscape
9.9.3 Strategic outlook
9.9.4 SWOT analysis
9.10 Medtronic plc
9.10.1 Financial data
9.10.1.1 Sales revenue, 2021-2024 (USD Million)
9.10.2 Product landscape
9.10.3 Strategic outlook
9.10.4 SWOT analysis
9.11 Olympus Corporation
9.11.1 Financial data
9.11.1.1 Sales revenue, 2021-2024 (USD Million)
9.11.2 Product landscape
9.11.3 Strategic outlook
9.11.4 SWOT analysis
9.12 RICHARD WOLF
9.12.1 Financial data
9.12.2 Product landscape
9.12.3 SWOT analysis
9.13 Smith & Nephew plc
9.13.1 Financial data
9.13.1.1 Sales revenue, 2021-2024 (USD Million)
9.13.2 Product landscape
9.13.3 Strategic outlook
9.13.4 SWOT analysis
9.14 Stryker Corporation
9.14.1 Financial data
9.14.1.1 Sales revenue, 2021-2024 (USD Million)
9.14.2 Product landscape
9.14.3 Strategic outlook
9.14.4 SWOT analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings